User: OPTILAB CHUM
Cancer cells release fragments of DNA into the blood, carrying unique mutations that can act as precise markers for the disease. This project aims to use whole genome sequencing (WGS) of circulating tumour DNA (ctDNA) for more efficient cancer diagnosis and treatment monitoring. Unlike current ctDNA testing, which is costly and time-consuming, WGS offers a generalized assay paired with personalized computational analysis, simplifying the process and reducing costs.
Establishing this sequencing platform in Québec will create skilled jobs in genomics, drive economic growth, and position Québec as a leader in precision healthcare. WGS also enhances patient care by enabling earlier, more accurate treatment assessments, reducing unnecessary treatments, and improving quality of life. This approach promotes healthcare equity, as the simple blood tests required can be performed at any healthcare facility, making cutting-edge diagnostics accessible even in remote and underserved communities.